Baader Bank Aktiengesellschaft’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,900
Closed -$2.63M 533
2025
Q4
$2.63M Buy
+10,900
New +$2.79M 0.18% 96
2025
Q3
Sell
-10,600
Closed -$2.73M 590
2025
Q2
$2.73M Sell
10,600
-10,600
-50% -$2.53M 0.2% 105
2025
Q1
$4.75M Sell
21,200
-9,800
-32% -$2.29M 0.36% 89
2024
Q4
$7.09M Sell
31,000
-5,000
-14% -$1.2M 0.46% 69
2024
Q3
$8.79M Hold
36,000
0.51% 61
2024
Q2
$6.89M Buy
+36,000
New +$7.3M 0.44% 78

Other funds holding RMD

Baader Bank Aktiengesellschaft's RMD Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft reduced its ResMed (RMD) stake by 80% in Q1 2026, selling an estimated $4.63M and leaving 4,768 shares worth $1.04M. The position accounts for 0.08% of the portfolio, ranked #171.

Baader Bank Aktiengesellschaft first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. The position peaked at $9.14M in Q3 2024. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Baader Bank Aktiengesellschaft held 4,768 shares of ResMed worth $1.04M as of Q1 2026.
  • Baader Bank Aktiengesellschaft sold 18,596 ResMed shares in Q1 2026, an estimated $4.63M.
  • ResMed made up 0.08% of Baader Bank Aktiengesellschaft's portfolio in Q1 2026, its #171 holding.
  • Baader Bank Aktiengesellschaft first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
  • Baader Bank Aktiengesellschaft's ResMed position peaked at $9.14M in Q3 2024.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.